Main Menu

From Patent to Patient: our report analysing access to innovative cancer drugs

Our report asks how we can best harness advances in science to bring innovative drugs to patients. It is designed to help us reshape the landscape for drug discovery and development – and create tomorrow’s cancer treatments.

We set out to assess the current landscape for drug discovery and development by analysing every cancer drug first licensed through the European Medicines Agency (EMA) from 2000 to 2016.

Our report highlights the progress that is being made with discovering exciting new cancer medicines. But it also draws attention to key challenges that will need to be overcome to ensure more patients can benefit from these advances.

Download the report (PDF, 739KB)

News: New cancer drugs taking longer to reach NHS patients

NHS patients are waiting longer for new cancer drugs because of delays in taking them through clinical trials and getting them approved for use, a major new analysis of regulatory data reveals.

Read more

Template: Contact your MP via email and social media

Contacting your MP about the issues highlighted in the Patent to Patient – analysing access to innovative cancer drugs report, is a fantastic way to get these issues in front of the people with power, so we can make change happen to improve outcomes for people living with cancer.

Download the template

Blog: Why regulators must move with the science if we’re to get innovative new treatments to patients more quickly

Our CEO, Professor Paul Workman, discusses the findings of the ICR's new drug access report, which asks how we can best harness advances in science to bring innovative drugs to patients.

Read more

Feature: Making it count – the real life stories of people benefiting from innovative new cancer treatments

We are in an exciting time in cancer research, with many researchers believing we are at the tipping point in cancer treatment, and moving towards truly personalised treatment plans for patients.

Read more

Video: Are new cancer drugs reaching cancer patients fast enough?

Dr Olivia Rossanese talks about our new drug access report – From Patent to Patient – and whether or not new cancer drugs are reaching cancer patients fast enough.

Watch

Video: How palbociclib helps Christine live her life with secondary breast cancer

We spoke to Christine, who has secondary breast cancer, about her experience with the innovative new drug palbociclib. The ICR and The Royal Marsden ran clinical trials of palbociclib, which is now available on the NHS.

Watch

Video: Rob's prostate cancer story and successful treatment with abiraterone

We met Rob Lester who told us about his experience of being treated for advanced prostate cancer with abiraterone - a drug discovered by the ICR.

Watch

Video: Anne talks about ovarian cancer and drug olaparib

We spoke to Anne and heard about her ovarian cancer story and experiences with cancer drug olaparib.

Watch

Video: Melanoma patient Debbie tells us how dabrafenib has given her hope

Debbie Keynes spoke to us about her experience of being diagnosed with melanoma and subsequent treatment with cancer drug dabrafenib.

Watch
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.